Abstract Latent Epstein–Barr virus (EBV) infection has a substantial role in causing many
human disorders. The persistence of these viral genomes in all malignant cells, yet with the …

While the majority of Human papillomavirus (HPV) infections are transient and cleared
within a couple of years following exposure, 10–20% of infections persist latently, leading to …

The papillomavirus E2 protein tethers viral genomes to host mitotic chromosomes to ensure
genome maintenance. We have identified the bromodomain protein Brd4 as a major cellular …

The Epstein-Barr nuclear antigen-1 (EBNA1) protein of Epstein-Barr virus is important for the
replication, segregation, and transcriptional activation of latent Epstein-Barr virus genomes; …

Epstein–Barr virus (EBV; human herpesvirus 4; HHV‐4) and Kaposi sarcoma‐associated
herpesvirus (KSHV; human herpesvirus 8; HHV‐8) are human gammaherpesviruses that …

ABSTRACT Kaposi's sarcoma (KS)-associated herpesvirus (KSHV)(also known as human
herpesvirus 8) latently infects KS tumors, primary effusion lymphomas (PELs), and PEL cell …

An important reason for preferring mammalian cells for heterologous gene expression is
their ability to make authentic proteins containing post‐translational modifications similar to …

The Epstein–Barr virus (EBV) nuclear antigen 1 (EBNA1) is one of the earliest viral proteins
expressed after infection and is the only latent protein consistently expressed in viral …

Epstein–Barr nuclear antigen 1, or EBNA‐1, is required for the replication of the EBV
genome as an extra‒chromosomal element and is a key transcriptional regulator of this …

Abstract The human gammaherpesviruses Epstein–Barr virus (EBV) and Kaposi's sarcoma-
associated herpesvirus (KSHV) establish long-term latent infections associated with diverse …